Fig. 4From: The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing indexPatient wellbeing according to the WHO-5 wellbeing index. Error bars represent standard deviations. *** significant for each assessment versus baseline, p < 0.001Back to article page
